1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Alpha-1 antitrypsin for treating high-risk acute graft-versus-host disease after a haematopoietic stem cell transplant in people 12 years and over [TSID12036]

Awaiting development [GID-TA11596] Expected publication date: TBC

  • Project information
  • Project documents

28719-Alpha-1-Antitrypsin-for-Graft-Versus-Host-Disease-V1.0-APR2024-NON-CONF.pdf (nihr.ac.uk)